Although genome-wide association studies have successfully identified thousands of risk loci for complex traits, only a handful of the biologically causal variants, responsible for association at these loci, have been successfully identified. Current statistical methods for identifying causal variants at risk loci either use the strength of association signal in an iterative conditioning framework, or estimate probabilities for variants to be causal. A main drawback of existing methods is that they rely on the simplifying assumption of a single causal variant at each risk locus which is typically invalid at many risk loci. In this work, we propose a new statistical frameworks that allows for the possibility of an arbitrary number of causal variants when estimating the posterior probability of a variant being causal. A direct benefit of our approach is that we predict a set of variants for each locus that under reasonable assumptions will contain all of the true causal variants with a high confidence level (e.g. 95%) even when the locus contains multiple causal variants. We use simulations to show that our approach provides 20-50% improvement in our ability to identify the causal variants compared to the existing methods at loci harboring multiple causal variants. We validate our approach using empirical data from a eQTL study of CHI3L2 to identify new causal variants that affect gene expression at this locus.
INTRODUCTION
Although genome-wide association studies (GWAS) reproducibly identified thousands of risk loci only a handful of causal genetic variants (i.e. variants that biologically alter disease risk) have been found, thus prohibiting the mechanistic understanding of genetic basis of common diseases. The linkage disequilibrium (LD) structure of the human genome has greatly benefited GWAS in interrogating only a subset of all variants to assay common variation across the genome. Unfortunately, LD hinders the identification of causal variants at risk loci in fine-mapping studies as at each locus, there are often tens to hundreds of variants tightly linked to the reported associated single-nucleotide polymorphism (SNP). In a continued effort to identify causal variants, many fine-mapping studies that assess genetic variation at known GWAS risk loci are currently underway.
Fine-mapping studies typically follow a two-step procedure. First, a statistical analysis of the association signal is performed to identify a minimum set of SNPs that can explain the signal. Second, the SNPs that are putatively casual are functionally tested using laborious and expensive functional assays. Therefore, the objective of the statistical component of fine-mapping is to minimize the number of SNPs that need to be selected for follow-up studies while identifying the true causal SNPs. In this work, we focus on developing approaches for statistical refinement of the association signal with the goal of identifying the minimum set of variants to be tested to identify all the causal variants.
METHODS
Overview of statistical fine-mapping.
Our approach, CAVIAR (CAusal Variants Identification in Associated Regions), takes as input the association statistics for all of the SNPs (variants) at the locus together with the correlation structure between the variants obtained from a reference dataset such as the HapMap or 1000 Genomes project data. Using this information, our method predicts a subset of the variants that has the property that all the casual SNPs are contained in this set with the probability ρ (we term this set as the "ρ causal set"). In practice we set ρ to values close to 100%, typically greater than or equal to 95% and let CAVIAR find the set with the fewest number of SNPs which contains the causal SNPs with probability at least ρ. The casual set can be viewed as a confidence interval. We use the casual set in the follow up studies by validating only the SNPs that are present in the set.
Data-generating model for fine-mapping studies
We consider a genome-wide association study (GWAS) on a quantitative trait where n individuals are genotyped on m SNPs. For individual k, we are given the phenotypic value y k and the genotype values at m SNPs, where for SNP i, g ik ∈ {0, 1, 2} is the minor allele count. Let y denote the (n × 1) vector of the phenotypic values and xi denote the (n × 1) vector of normalized genotype values at SNP i such that 1 T xi = 0 and x T i xi = n.Let's assume that a SNP c is the only SNP involved in the disease. We assume the data generating model follows a linear model,
For simplicity, we assume the sample size n is large-enough, such that the association statistic Sc is well approximated by a normal distribution with NCP λc = βc σ √ n and unit variance, Sc ≈ N (λc, 1) .
Furthermore, if SNP i is correlated with a disease involved SNP c with coefficient r, i.e.
1 n x T i xc, the estimate of its effect-size follows,
The covariance between the two normal random variables
A new framework for computing the posterior probability of causal SNP statuses from GWAS data
Consider we are given a set of m SNPs M, with their pairwise correlation coefficients Σ. We introduce a new parameter, c, an (m × 1) causal status indicator vector, ci denoting an element for that vector. There are three possible causal status for each SNP: positive effect (ci = +1), negative effect (ci = −1), and no effect ci = 0. The indicator vector c can take 3 m possible causal statuses, denoted by the set C, with 3 m − 1 of them having at least one causal SNP. We denote the association statistics of the SNPs by the (m × 1) vector S = S1 . . . Sm T , which follows a multi-
where, for simplicity in presenting the model, we assume all causal SNPs have the same NCP, λc. Let c * ∈ C denote a particular causal status.
Given the observed association statistics of the m SNPs, s = ŝ1 . . .ŝm T , the posterior probability of the causal status P (c * |ŝ) can be expressed as,
Given a set of SNPs K ⊂ M, we denote the set of causal SNP configurations rendered by K with CK, which excludes all causal SNP configurations having a SNP outside of K as causal. Note that, our definition for CK includes the null configuration of having no causal SNPs as well. Using CK, we can compute the posterior probability of K to include, or capture, all the causal SNPs,
We denote the value of this posterior probability with ρ, where ρ = P (CK|ŝ), and refer to it as the confidence level of K in capturing the causal SNPs. Similarly, we refer K as a "ρ confidence-set of causal SNPs" or a "ρ confidence-set".
Given a minimum confidence threshold ρ * , there can be many confidence-sets, each having a confidence level that is greater than the threshold. Among all these sets, the ones with smaller number of SNPs are more informative, or have higher resolution, in locating the causal SNPs. Then, the problem we are interested is to find the ρ * confidence-set with the minimum size,
where K * has the minimum size.
CONCLUSIONS
In this paper, we present a novel framework for identifying the causal variants underlying GWAS risk loci. The key idea behind our framework is that instead of considering each variant one at a time, we instead analyze all of the variants in the entire locus simultaneously. The result of our method is a set of variants which with high probability contains (or captures) all the causal variants. Through extensive simulation results, we show that our approach is superior to existing methods in reducing the overall number of variants to be examined in functional follow-up to identify the causal variants.
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